<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Oral sub mucous fibrosis </title>
      <link rel="shortcut icon" href="./uma.jfif" type="image/x-icon">
</head>
<body style="font-family: 'Times New Roman', Times, serif; background-color: rgb(254, 105, 105);color: whitesmoke; text-align: justify; margin-left: 50px; margin-right: 50px;">
   <h2> DEFINITION</h2>
   <p style="margin-left: 30px; margin-right: 30px;">“Oral sub mucous fibrosis is an insidious chronic disease affecting any part of oral cavity and Sometimes the Pharynx. Although occasionally preceded by and for associated with veride formation; It is always associated with junta epithelial Inflammatory reaction followed by hobro elastic change of lamina propria with epithelial atrophy leading to stiffness of mucosa and Causing trismus and inability to eat."
<pre style="margin-left: 1150px;; ">
    <em>[PINDBORG JJ, SIRSAT SM 1960]</em>
</pre> 
    </p>
    <h3>ETIOLOGY</h3>
    <ul>
        <li>Nutritional deficiency</li>
        <li>Chillies</li>
        <li>Arecunut chewing</li>
        <li>Immunological process</li>
    </ul>
    <h3>
        CLINICAL FEATURES
    </h3>
    <ul>
        <li>Burning sensation</li>
        <li>Inability to eat spray food</li>
        <li>Blanding of mucosa</li>
        <li>Progressive reduction in mouth opening</li>
        <li>Thick palpable fibrous bands in buccal and labial mucosa</li>
        <li>Difficulty to protrude tongue.</li>
        <li>Veside formation in oral mucosa</li>
        <li>Wasal voice</li>
    </ul>
    <h2>Classification Based on Clinical Features
    <em>[Khanna JN, Andrade NN, 1995]</em></h2>
    <h3>Group I : Very early </h3>
    <ul>
        <li>Decreases mouth opening is normal</li>
        <li>Burning sensation</li>
        <li>Excessive salivation</li>
        <li>Acute ulceration and recurrent stomatitis</li>
    </ul>

<h2>Group II : Early cases</h2>
<ul>
    <li>Decreased mouth opening 26-35mm (Inter inoisal opening)</li>
    <li>Soft palate and facial pillars primarily affected.</li>
    <li>Buccal mucosa appears mottled and marble-like dense Pale</li>
    <li>Red enpthematous patches</li>
</ul>
<h3>Group III : Moderately advanced</h3>
<ul>
    <li>Used mouth opening 15-25mm</li>
    <li>Trismus</li>
    <li>Unable to blow out their cheek and white</li>
    <li>Vertical fibrous bands could be palpated and firmly attached to underlying tissue</li>
    <li>Atrophy of vermillion border of lips</li>
</ul>
<h3>Group IV(a) : Advanced cases</h3>
<ul>
    <li>Decreased mouth opening 2-15</li>
    <li>Stiffness</li>
    <li>Trismus</li>
    <li>Tongue movement restricted</li>
    <li>Papillary atrophy</li>
</ul>
<h3>Group IV(b) : Advanced cases with premalignant and malignant changes</h3>	
<ul>
    <li>OSMF and leuboplatia </li>
    <li>OSMF, Squamous cell coscinoma</li>
</ul>
<h3>STAGING
    <em>[PINDBORG JJ, 1989]</em></h3>
<h3>1.	Stage I :</h3> 
<ul>
    <li>Stomatitis including enthematous mucosa, resides, mucosal ulcers, molanobc pigmentation & mucosal potechine.</li>
</ul>
<h3>2.	Stage II :</h3>	
<ul>
    <li>Fibrosis occurs in healing veride & ulcers, whivh is hall mark of this stage.</li>
    <li>Early lesions show blanding of oral mucosa.</li>
    <li>Older lesions show vertical & circular palpable fibrous bands in buccul mucosa.</li>
    <li>This results in mottled marble like appearance.</li>
</ul>
<h3>3.	Stage III :  Sequela of OSMF are as follows</h3>
<ul>
    <li>Leukoplatia is formed in more than 25% of individual with OSMF.</li>
    <li>Speech amd hearing defect may occur because of involvement of tongue & eustruchian tube.</li>
</ul>
<h3>LABORATORY FINDINGS</h3>
<ul>
    <lli>Decreased haemoglobin levels.</lli>
    <lli>Decreased iron levels.</lli>
    <lli>Decreased protein levels.</lli>
    <lli>Increased entrosyte sedimentation rate.</lli>
    <lli>Decreased vitamin B complex levels.</lli>
</ul>
<h3>HISTOPATHOLOGY</h3>
<ul>
    <li>Epithelial atropy</li>
    <li>Parol ortho teratosis</li>
    <li>Connective tissue shows severe hyalinization, fibroblasts are diminished and blood vessels obliterated.
        Dysplati:- In very early stages, sub mucus  loper shows marted Dedema, large fibroblast cruel collagen fibres.</li>
    <li>Early stage: Hyalinization, thickened collagen fibres and fibroblasts.</li>
    <li>Moderately advanced and advanced stage:  Janath epithelial hyalinization, inflammatory cell infiltration, lymbosytes and plasma cells.</li>
    <li>Pindborg (1984) observed a 45% malignant transformation.
    </li>
</ul>
 <h3>MANAGEMENT </h3>
<ol>
    <li>Discontinuation of habit and counselling.</li>
    <li>Supportive care.</li>
    <li>Medical management.</li>
    <li>Other therapies.</li>
    <li>Oral physiotherapy.</li>
    <li>Diathermy.</li>
    <li>Ultrasound.</li>
    <li>Surgical treatment.</li>
</ol>
<h4>1.	DISCONTINUATION OF HABIT AND COUNCSELLING</h4>
<ul>
    <li>Encouraged through educations and advocacy.</li>
    <li>Patient should be explained about disease and its possible malignant potential.</li>
    <li>Thorough counselling should be for de addiction.</li>
</ul>
<h4>2.	SUPPORTIVE CARE</h4>
<ul>
    <li>Vitamins, Iron and mineral rich diet should be advised to patents with OSMF.</li>
    <li>Intake of red tomatoes, Sesh fruits and green leafy vegetables should be Included be included in diet chat.</li>
    <li>Routine levels followed by iron supplements.</li>
</ul>
<h4>3.	MEDICAL MANAGEMENT</h4>
<ul>
    <h5>I. STEROIDS :-</h5>
    <li>Inhibits proliferation of fibroblasts.</li>
    <li>Inhibit inflammatory response.</li>
    <li>Release cellular proteases in connective tissue extra-cellular compartment.</li>
</ul>
    
  <ul><h5>II. HYALURONIDASE :-</h5>
    <li>Reduces burning sensation & frishes.</li>
    <li>Decreases collagen formation.</li>
    <li>Combination of steroids and hyaluronidase shows better long term results than either agent used alone.</li>
</ul>
<ul>
    <h5>III.	PLACENTAL EXTRACTS :-</h5>
    <li>It is an aqueous extract of human planta that Contains nucleohole, enzymes and vitamins, ao, and steroid.</li>
    <li>It is a biogenic stimulus.</li>
    <li>Its use is based on method of “tissue therapy” introduced by Filator in 1933.</li>
</ul>
<ul>
    <h5>IV.	CHYMOTRYPSIN :-</h5>
    <li>An endopeptidase, hydrolyse enter & pepdide bond, thus acting as a protolytz & anti-inflammatory agent.</li>
</ul>
 <ul>
    <h5>V.	INTERFERON GAMMA :-</h5>
    <li>Has immune regulatory effect, known as anti brolic cytokine.</li>
    <li>Patients treated with IFN-Y experienced improved systems.</li>
 </ul>
<ul>
    <h5>VI.	IMMUNE MILK</h5>
    <li>Skimmed milk produced from cows immunised with multiple human latertinal bacteria.</li>
</ul>	
<ul>
    <h5>VII.	TURMERIC </h5>
    <li>Offers problem against benzopyrene induced increase in micronude in circularly lymphocyts.</li>
    <li>Excellent scavenger of free radical in viho.</li>
</ul>	
<ul>
    <h3>OTHER THERAPIES</h3>
    <li>Infection of Gold, vitamin A and Collagenase.</li>
    <li>Vasodilator infection can be used.</li>
    <li>Chemotherapeutic agents like topical ikonyan be used in severe cases.</li>
</ul> 
<h4>ORAL PHYSIOTHERAPY</h4>
<ul>
    <li>Muscle stretching exercises.</li>
    <li>Includes forceful mouth opening with help of sticks ballooning of mouth, hot water gargling.</li>
    <li>Forceful mouth opening with moath gag & acrylic surgical screw.</li>
    <li>This is thought to put pressure on fibrous bands.</li>
</ul>
<h4>DIATHERMY</h4>
<ul>
    <li>Microware diathermy (low current is used 20watts X 24150 cycles) is useful in some early advanced stages.</li>
    <li>Acts by fibrinolysis of bands</li>
</ul>
<h4>ULTRA SOUND</h4>	
<ul>
    <li>Selectively raises the temperature in some well circumscribed areas.</li>
    <li>Efficient deep heating modality.</li>
    <li>Frequency about 0.8-1MHz and intensity of 0.5-3w/cm2</li>
</ul>
<h4>SURGICAL TREATMENT</h4>
<ul>
    <li>Simple excision of fibrous bands.</li>
    <li>Split - thickness skin grafting following bilateral temperats myofony or coronoideotomy.</li>
    <li>Nasalabial Slaps and lingual pedicle flaps to create flaps is performed only in subject in whom tongue is not involved.</li>
    <li>CO2-LASER Surgery offers advantage in alleviating the functional restriction.</li>
    <li>Cryosurgery-Liquid nitrogen or Argon gas used preferably as sprays through “ago probe” MRI/USG. The frozen tissues thans & is either naturally absorbed by body or dissolves & forms a Scab.
    </li>
</ul>
   
</body>
</html>
